Perioperative Exhaled Nitric Oxide as an Indicator for Postoperative Pneumonia in Surgical Lung Cancer Patients: A Prospective Cohort Study Based on 183 Cases
Table 2
Characteristics of patients with POP.
Gender
Age (years)
Comorbidity
FEV1 (L)
DLCO (Ml/min/mmHg)
Pre-FeNO (ppb)
Post-FeNO (ppb)
Change in FeNO (ppb)
Onset of POP
Bacteria
Duration of antibiotic use (days)
F
68
COPD
1.68
16.92
23.00
28.00
5.00
POD 3
NA
5.00
M
64
COPD
1.32
19.83
26.00
36.00
10.00
POD 5
K. pneumoniae
7.00
F
69
DM
2.83
17.08
22.00
21.00
−1.00
POD 2
NA
5.00
M
66
—
1.89
20.85
20.00
30.00
10.00
POD 2
NA
5.00
F
53
2.40
19.72
28.00
30.00
2.00
POD 2
NA
4.00
M
56
—
3.73
35.55
20.00
26.00
6.00
POD 3
NA
6.00
M
73
COPD
2.23
16.78
35.00
74.00
39.00
POD 1
NA
4.00
F
50.
—
2.39
20.40
8.00
20.00
12.00
POD 2
NA
5.00
M
48
CVD
3.60
29.00
21.00
30.00
9.00
POD 3
NA
3.00
M
57
—
4.19
29.50
14.00
31.00
17.00
POD 2
NA
4.00
F
62
COPD
1.73
21.23
19.00
10.00
−9.00
POD 4
P. aeruginosa
9.00
F
62
DM
2.33
24.81
21.00
32.00
11.00
POD 2
NA
5.00
M
62
—
2.40
21.85
15.00
37.00
22.00
POD 3
NA
4.00
M
73
CVD
2.44
16.02
16.00
23.00
7.00
POD 2
E. coli
6.00
F
75
CVD
2.44
19.50
18.00
29.00
11.00
POD 4
NA
8.00
M
60
—
2.45
21.32
18.00
46.00
28.00
POD 3
NA
3.00
F
44
—
3.03
26.34
27.00
54.00
27.00
POD 2
NA
5.00
M
48
—
2.30
18.36
28.00
38.00
10.00
POD 4
NA
3.00
F
73
CVD
2.30
20.48
29.00
67.00
38.00
POD 2
E. coli
6.00
POP: postoperative pneumonia; F/M: female/male; COPD: chronic obstructive pulmonary disease; CVD: cardiovascular disease, including hypertension and coronary heart disease; DM: diabetes mellitus; FEV1: forced expiratory volume in 1 s; DLCO: diffusion capacity of the lung for carbon monoxide; POD: postoperative day; E. coli: Escherichia coli; P. aeruginosa: Pseudomonas aeruginosa; K. pneumoniae: Klebsiella pneumoniae; FeNO: fractional exhaled nitric oxide.
